Psyence Biomedical (Psyence Biomedical) Asset Impairment Charge : $0.00 Mil (TTM As of Mar. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Asset Impairment Charge?

Psyence Biomedical's Asset Impairment Charge for the six months ended in Mar. 2023 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00 Mil.

Psyence Biomedical Asset Impairment Charge Historical Data

The historical data trend for Psyence Biomedical's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Asset Impairment Charge Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

Asset Impairment Charge

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
Asset Impairment Charge	-	-	-

Psyence Biomedical Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00 Mil.

Psyence Biomedical Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024